Research Article
Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development
Nina J. Chu, Robert A. Anders, Elana J. Fertig, Minwei Cao, Alexander C. Hopkins, Bridget P. Keenan, Aleksandra Popovic, Todd D. Armstrong, Elizabeth M. Jaffee and Jacquelyn W. Zimmerman
Nina J. Chu
1Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
Robert A. Anders
1Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
2Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland.
Elana J. Fertig
1Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
3Department of Applied Mathematics and Statistics, Whiting School of Engineering, Johns Hopkins University, Baltimore, Maryland.
4Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, Maryland.
Minwei Cao
1Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
Alexander C. Hopkins
1Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
Bridget P. Keenan
1Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
5Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
Aleksandra Popovic
1Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
Todd D. Armstrong
1Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
Elizabeth M. Jaffee
1Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
Jacquelyn W. Zimmerman
1Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
DOI: 10.1158/1940-6207.CAPR-20-0053 Published July 2020

This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
July 2020
Volume 13, Issue 7
Volume 13, Issue 7
Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development
Nina J. Chu, Robert A. Anders, Elana J. Fertig, Minwei Cao, Alexander C. Hopkins, Bridget P. Keenan, Aleksandra Popovic, Todd D. Armstrong, Elizabeth M. Jaffee and Jacquelyn W. Zimmerman
Cancer Prev Res July 1 2020 (13) (7) 569-582; DOI: 10.1158/1940-6207.CAPR-20-0053
Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development
Nina J. Chu, Robert A. Anders, Elana J. Fertig, Minwei Cao, Alexander C. Hopkins, Bridget P. Keenan, Aleksandra Popovic, Todd D. Armstrong, Elizabeth M. Jaffee and Jacquelyn W. Zimmerman
Cancer Prev Res July 1 2020 (13) (7) 569-582; DOI: 10.1158/1940-6207.CAPR-20-0053
Jump to section
Advertisement